{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:30:01Z","timestamp":1790515801882,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.nbd.2018.11.015","type":"journal-article","created":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T19:00:58Z","timestamp":1542913258000},"page":"248-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["P\u03b1-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria"],"prefix":"10.1016","volume":"124","author":[{"given":"Diego","family":"Grassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Diaz-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Volpicelli-Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne Ida","family":"Lasm\u00e9zas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2018.11.015_bb0005","doi-asserted-by":"crossref","first-page":"30851","DOI":"10.1074\/jbc.M110.110957","article-title":"Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration","volume":"285","author":"Alonso","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.11.015_bb0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s004010050917","article-title":"NACP\/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy","volume":"96","author":"Arima","year":"1998","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1086\/302486","article-title":"Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein","volume":"65","author":"Athanassiadou","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0020","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.12.003","article-title":"Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system","volume":"22","author":"Betarbet","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2018.11.015_bb0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J. Microsc."},{"key":"10.1016\/j.nbd.2018.11.015_bb0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1021\/cn100109k","article-title":"Small molecule c-Jun-N-terminal kinase (JNK) inhibitors protect dopaminergic neurons in a model of Parkinson's disease","volume":"2","author":"Chambers","year":"2011","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2018.11.015_bb0035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1534-5807(03)00094-7","article-title":"JNK1 is required for maintenance of neuronal microtubules and controls phosphorylation of microtubule-associated proteins","volume":"4","author":"Chang","year":"2003","journal-title":"Dev. Cell"},{"key":"10.1016\/j.nbd.2018.11.015_bb0040","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0045","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.4049\/jimmunol.1001250","article-title":"Oxidative phosphorylation induces de novo expression of the MHC class I in tumor cells through the ERK5 pathway","volume":"185","author":"Charni","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0050","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41419-018-0722-7","article-title":"Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T alpha-synuclein model of Parkinson's disease","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.nbd.2018.11.015_bb0055","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1471-4159.2004.02155.x","article-title":"Primed phosphorylation of tau at Thr231 by glycogen synthase kinase 3beta (GSK3beta) plays a critical role in regulating tau's ability to bind and stabilize microtubules","volume":"88","author":"Cho","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2018.11.015_bb0060","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/NEN.0b013e3181db8100","article-title":"JNK3 mediates paraquat- and rotenone-induced dopaminergic neuron death","volume":"69","author":"Choi","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.1552","article-title":"Manganese modulation of MAPK pathways: effects on upstream mitogen activated protein kinase kinases and mitogen activated kinase phosphatase-1 in microglial cells","volume":"31","author":"Crittenden","year":"2011","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1357-2725(00)00003-0","article-title":"Mitogen-activated protein kinase kinase 4 (MKK4)","volume":"32","author":"Cuenda","year":"2000","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0075","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1172\/JCI200317575","article-title":"Rare genetic mutations shed light on the pathogenesis of Parkinson disease","volume":"111","author":"Dawson","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2018.11.015_bb0080","doi-asserted-by":"crossref","first-page":"342ra378","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"Alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0085","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1096\/fj.08-120410","article-title":"Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models","volume":"23","author":"Duka","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2018.11.015_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075025","article-title":"Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases","volume":"8","author":"Duka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.11.015_bb0095","doi-asserted-by":"crossref","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","article-title":"A practical guide to evaluating colocalization in biological microscopy","volume":"300","author":"Dunn","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molmed.2005.01.001","article-title":"Gene dosage and pathogenesis of Parkinson's disease","volume":"11","author":"Eriksen","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrg1831","article-title":"Genetics of Parkinson disease: paradigm shifts and future prospects","volume":"7","author":"Farrer","year":"2006","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0110","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s007020100015","article-title":"Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK\/ERK), stress-activated protein kinase\/c-Jun N-terminal kinase (SAPK\/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies","volume":"108","author":"Ferrer","year":"2001","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.nbd.2018.11.015_bb0115","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.neuron.2005.07.021","article-title":"Nosology of Parkinson's disease: looking for the way out of a quagmire","volume":"47","author":"Forman","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.11.015_bb0120","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/mds.27372","article-title":"International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease","volume":"33","author":"Fox","year":"2018","journal-title":"Mov. Disord"},{"key":"10.1016\/j.nbd.2018.11.015_bb0125","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.58.2.186","article-title":"Synucleinopathies: clinical and pathological implications","volume":"58","author":"Galvin","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-018-0245-9","article-title":"Tau oligomers mediate alpha-synuclein toxicity and can be targeted by immunotherapy","volume":"13","author":"Gerson","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.11.015_bb0135","doi-asserted-by":"crossref","first-page":"E2634","DOI":"10.1073\/pnas.1713849115","article-title":"Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinson's disease","volume":"115","author":"Grassi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.11.015_bb0140","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cell.2013.05.057","article-title":"Distinct alpha-synuclein strains differentially promote tau inclusions in neurons","volume":"154","author":"Guo","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2018.11.015_bb0145","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/j.1460-9568.2011.07660.x","article-title":"Hyperphosphorylated Tau in an alpha-synuclein-overexpressing transgenic model of Parkinson's disease","volume":"33","author":"Haggerty","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2018.11.015_bb0150","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"Alpha-synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2018.11.015_bb0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","article-title":"JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson's disease","volume":"101","author":"Hunot","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.11.015_bb0160","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrn3549","article-title":"Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies","volume":"14","author":"Irwin","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2018.11.015_bb0165","article-title":"The role of alpha-Synuclein and LRRK2 in tau phosphorylation","volume":"2015","author":"Kawakami","year":"2015","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.nbd.2018.11.015_bb0170","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1399-0004.2007.00781.x","article-title":"The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease","volume":"71","author":"Ki","year":"2007","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0175","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2018.11.015_bb0180","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1212\/01.wnl.0000271880.27321.a7","article-title":"Parkinson disease, 10 years after its genetic revolution: multiple clues to a complex disorder","volume":"69","author":"Klein","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2018.11.015_bb0185","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0190","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0298-106","article-title":"Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease","volume":"18","author":"Kruger","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0195","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.bbi.2018.02.012","article-title":"Alpha-synuclein oligomers impair memory through glial cell activation and via Toll-like receptor 2","volume":"69","author":"La Vitola","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2018.11.015_bb0200","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0205","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0210","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Lasagna-Reeves","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.11.015_bb0215","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0220","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4","article-title":"Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease","volume":"45","author":"Lippa","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0225","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1186\/s12906-017-2023-6","article-title":"Antitumor effect of Quercetin on Y79 retinoblastoma cells via activation of JNK and p38 MAPK pathways","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0230","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41467-017-00664-8","article-title":"Metabolic stress-induced cardiomyopathy is caused by mitochondrial dysfunction due to attenuated Erk5 signaling","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2018.11.015_bb0235","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.11.015_bb0240","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2018.11.015_bb0245","doi-asserted-by":"crossref","first-page":"21490","DOI":"10.1074\/jbc.M113.545749","article-title":"Soluble, prefibrillar alpha-synuclein oligomers promote complex I-dependent, Ca2+\u2212induced mitochondrial dysfunction","volume":"289","author":"Luth","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2018.11.015_bb0250","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/hmg\/dds072","article-title":"Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage","volume":"21","author":"Manczak","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0255","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1531-8249(199909)46:3<374::AID-ANA13>3.0.CO;2-9","article-title":"Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism","volume":"46","author":"Markopoulou","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0260","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","article-title":"Recent advances in the genetics of Parkinson's disease","volume":"12","author":"Martin","year":"2011","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0265","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.arr.2012.06.003","article-title":"Tau protein kinases: involvement in Alzheimer's disease","volume":"12","author":"Martin","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.nbd.2018.11.015_bb0270","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2018.11.015_bb0275","article-title":"Small peptide inhibitor of JNK3 protects dopaminergic neurons from MPTP induced injury via inhibiting the ASK1-JNK3 signaling pathway","volume":"10","author":"Pan","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2018.11.015_bb0280","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00439-008-0582-9","article-title":"Genomewide association study for susceptibility genes contributing to familial Parkinson disease","volume":"124","author":"Pankratz","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.nbd.2018.11.015_bb0285","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.11.015_bb0290","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.freeradbiomed.2015.06.041","article-title":"MPTP activates ASK1-p38 MAPK signaling pathway through TNF-dependent Trx1 oxidation in parkinsonism mouse model","volume":"87","author":"Ray","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2018.11.015_bb0295","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(14)61010-2","article-title":"Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives","volume":"384","author":"Schapira","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2018.11.015_bb0300","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-Synuclein and Tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2018.11.015_bb0305","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2018.11.015_bb0310","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.11.015_bb0315","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.67","article-title":"Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation","volume":"49","author":"Spira","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0320","doi-asserted-by":"crossref","first-page":"9685","DOI":"10.1007\/s11357-014-9685-5","article-title":"ERK5\/KLF4 signaling as a common mediator of the neuroprotective effects of both nerve growth factor and hydrogen peroxide preconditioning","volume":"36","author":"Su","year":"2014","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.nbd.2018.11.015_bb0325","doi-asserted-by":"crossref","first-page":"505607","DOI":"10.4061\/2011\/505607","article-title":"What are the bona fide GSK3 Substrates?","volume":"2011","author":"Sutherland","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2018.11.015_bb0330","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fnmol.2014.00042","article-title":"Protein phosphorylation in neurodegeneration: friend or foe?","volume":"7","author":"Tenreiro","year":"2014","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2018.11.015_bb0335","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.11.015_bb0340","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1091\/mbc.e14-02-0741","article-title":"Formation of alpha-synuclein Lewy neurite-like aggregates in axons impedes the transport of distinct endosomes","volume":"25","author":"Volpicelli-Daley","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.nbd.2018.11.015_bb0345","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","article-title":"Addition of exogenous alpha-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous alpha-synuclein to Lewy body and Lewy neurite-like aggregates","volume":"9","author":"Volpicelli-Daley","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2018.11.015_bb0350","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neures.2003.10.012","article-title":"SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"48","author":"Wang","year":"2004","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2018.11.015_bb0355","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/cdd.2015.135","article-title":"C-Abl-p38alpha signaling plays an important role in MPTP-induced neuronal death","volume":"23","author":"Wu","year":"2016","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2018.11.015_bb0360","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","article-title":"Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2018.11.015_bb0365","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/459265","article-title":"Diverse Roles of JNK and MKK Pathways in the Brain","volume":"2012","author":"Yamasaki","year":"2012","journal-title":"J. Signal. Transduct."},{"key":"10.1016\/j.nbd.2018.11.015_bb0370","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.neuron.2012.06.024","article-title":"JNK3 perpetuates metabolic stress induced by Abeta peptides","volume":"75","author":"Yoon","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2018.11.015_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","article-title":"Alpha-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism","volume":"13","author":"Yun","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2018.11.015_bb0380","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/ana.10795","article-title":"The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia","volume":"55","author":"Zarranz","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2018.11.015_bb0385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neuroscience.2016.02.007","article-title":"Mutations of glucocerebrosidase gene and susceptibility to Parkinson's disease: an updated meta-analysis in a European population","volume":"320","author":"Zhao","year":"2016","journal-title":"Neuroscience"},{"issue":"19","key":"10.1016\/j.nbd.2018.11.015_bb0390","first-page":"11","article-title":"Quantitative colocalization analysis of fluorescence microscopy images","volume":"4","author":"Zinchuk","year":"2014","journal-title":"Curr. Protoc. Cell Biol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118307034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996118307034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:11:43Z","timestamp":1775279503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996118307034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":78,"alternative-id":["S0969996118307034"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2018.11.015","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"P\u03b1-syn* mitotoxicity is linked to MAPK activation and involves tau phosphorylation and aggregation at the mitochondria","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2018.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}